Experimental evidence accumulated over the last two decades has demonstrated beneficial effects of VIP in all stages of RA development through its anti-inflammatory and immunomodulatory abilities [131,158,199] (Figure 2). This evidence concerns the gene VIP and rheumatoid arthritis.